Bicara Therapeutics Inc.
Q1 2025 13F Holders
Symbol
BCAX
CUSIP
055477103
Type
Equity
Class
COM
Num filings
93
Total reported value, excl. options
$633 M
Compare 2025 Q1 to
2025 Q3
2025 Q2
2024 Q4
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type